U.S. Consumer Services Stock News

Wondering if NextEra Energy is still a smart buy at around $81 a share, or if the easy gains are already behind it? Let us unpack whether the current price leaves any real upside on the table. Over the last week the stock has edged up 2.1%, but it is still down 3.1% over the past month, even though it is up 13.6% year to date and 16.0% over the last year, and 23.7% over five years. This pattern hints at a steady long term compounding story rather than a speculative spike. Recent headlines...

If you are wondering whether Intuit is still worth considering after its big run over the last few years, or if the easy money has already been made, you are not alone. The stock has inched up 2.1% over the last week and 1.0% over the past month, adding to a 76.4% gain over 3 years and 81.8% over 5 years, even though the 1 year return is slightly negative at -0.6%. Recent headlines have focused on Intuit doubling down on AI driven financial tools and expanding its ecosystem across...

UiPath (PATH) has quietly outperformed many software peers over the past 3 months, with the stock up about 36%, even after a choppy week that saw a pullback from recent highs. See our latest analysis for UiPath. That recent wobble comes after a strong run, with UiPath’s share price now at $16.09 and a solid 90 day share price return helping to offset a more modest 1 year total shareholder return. This suggests momentum is still broadly constructive as investors reassess its growth and...

PBF Energy (PBF) shares have been under pressure recently, sliding over the past month and past 3 months, and that drawdown is making value focused investors recheck the long term story. See our latest analysis for PBF Energy. Zooming out, PBF Energy’s recent sell off, including a sharp 1 day share price return of minus 10.99 percent and a 30 day share price return of minus 31.67 percent, contrasts with a 5 year total shareholder return of 343.82 percent. This suggests long term investors...

Royal Gold recently reported record third-quarter 2025 revenue but missed earnings-per-share expectations and at the same time announced a 6% increase in its annual dividend for 2026, to be paid quarterly from January 16, 2026. A director share sale of about US$109,145 and a higher dividend alongside an earnings miss give investors mixed signals about near-term profitability and capital returns. Next, we’ll examine how Royal Gold’s record revenue but weaker earnings reshape its investment...

Alexandria Real Estate Equities (ARE) is back in the spotlight after a cluster of securities class action filings and investigations tied to its tough third quarter, impairment charge and 45% dividend cut. See our latest analysis for Alexandria Real Estate Equities. The latest wave of litigation, leadership changes and a new share repurchase program all sit against a steep reset, with the share price now at $46.97 and a roughly 52% year to date share price decline. Multi year total...

NANO Nuclear Energy (NNE) has been drawing fresh attention after scheduling a Fiscal Year 2025 business update webcast and signing agreements to test its microreactors in real world data center and Texas facility settings. See our latest analysis for NANO Nuclear Energy. Those data center and Texas deployment plans seem to be shifting how investors are thinking about NANO Nuclear’s growth runway. The share price is at $32.31 after a 1 year to date share price return of 35.02 percent and a 1...

SLM (SLM) is back in focus after its recent Investor Forum prompted a wave of analyst revisions, with several firms trimming earnings forecasts and tempering their outlook on margins and operating costs. See our latest analysis for SLM. Those cautious revisions seem to be weighing on sentiment, with the share price at $26.84 and a slightly negative year to date share price return. However, the three and five year total shareholder returns of 75.9 percent and 141.0 percent suggest the longer...

Jefferies just upgraded Federal Realty Investment Trust (FRT) to Buy after the REIT ramped up its coastal footprint with acquisitions like Annapolis Town Center and Village Pointe, plus fresh board oversight from Joseph D. Fisher. See our latest analysis for Federal Realty Investment Trust. Even with this busy deal calendar, the stock’s 30 day share price return of just over 3 percent and slightly positive 3 year total shareholder return suggest momentum is only slowly rebuilding after a...

With a median price-to-sales (or "P/S") ratio of close to 0.8x in the Luxury industry in the United States, you could...

APA (APA) is back in focus after mixed Q3 results sent the stock up about 9% in a day, and the board followed up with a fresh 25 cent quarterly dividend declaration. See our latest analysis for APA. That post earnings pop came after a choppy spell, with the share price now at $23.96 and only a modest year to date share price return, but a stronger one year total shareholder return suggesting momentum is rebuilding as investors reassess APA’s cash generation and dividend support. If APA’s move...

CoreWeave (CRWV) has had a volatile stretch lately, with the stock sliding about 4 % in the past day and over 23 % this month, even as its AI infrastructure business continues to scale. See our latest analysis for CoreWeave. The recent slide reflects investors reassessing near term risk after a strong run, with the share price at 69.5 dollars and the year to date share price return still firmly positive. This suggests long term momentum is cooling but not broken. If CoreWeave’s swings have...

Blue Bird (BLBD) has quietly outperformed much of the market this year, and its recent pullback over the past 3 months is giving investors a fresh chance to revisit the story. See our latest analysis for Blue Bird. Behind that recent 3 month share price pullback, Blue Bird still carries a strong year to date share price return and a standout multi year total shareholder return, suggesting momentum is cooling but the longer term growth story remains very much intact. If Blue Bird has you...

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

JPMorgan Chase (JPM) keeps grinding higher, and with shares up around 31 % this year, investors are starting to ask a simple question: is there still enough upside left to matter? See our latest analysis for JPMorgan Chase. That move has come alongside a steady stream of solid earnings and resilience through rate uncertainty. With the share price now around 315.55 dollars, JPMorgan Chase’s strong year to date share price return and hefty multi year total shareholder returns suggest momentum...

Cintas Corporation’s recent past appearances in investor letters and on Jim Cramer’s show have spotlighted its role as a small-business barometer, as fund managers reassessed the company amid concerns about employment trends, pricing, and cost pressures despite better-than-expected quarterly results. These differing views underscore a tension between Cintas’ history of expanding services and free cash flow strength, and fresh worries that a softer employment backdrop and margin pressures...

Key Insights The considerable ownership by individual investors in TXO Partners indicates that they collectively have a...

Bunge Global SA ( NYSE:BG ) will pay a dividend of $0.70 on the 3rd of March. The payment will take the dividend yield...

If you are wondering whether Wells Fargo is still a value play after such a big run up, or if you might be arriving late to the party, this breakdown is for you. The stock has climbed 3.7% over the last week, 8.4% over the past month, and is now up 31.3% year to date and 33.0% over the last 12 months. That caps a multi year rebound of 143.3% over 3 years and 257.2% over 5 years. That surge has come as investors have steadily warmed back up to big US banks, with sentiment improving around...

Immunome (IMNM) grabbed investor attention after revealing that its pivotal Phase 3 RINGSIDE trial for desmoid tumors hit both its primary and key secondary endpoints, setting up a potential US approval filing in 2026. See our latest analysis for Immunome. The upbeat RINGSIDE data has been the clear catalyst behind Immunome’s recent rally, with a 30 day share price return of 36.99 percent and a 90 day share price return of 161.18 percent helping drive a 3 year total shareholder return of...

Insiders who acquired US$146.1k worth of Humacyte, Inc.'s ( NASDAQ:HUMA ) stock at an average price of US$1.38 in the...

If you are wondering whether Eaton is still worth buying after its big run over the last few years, you are not alone. This article is going to dig into what the current share price really implies. Despite long term gains of 120.9% over 3 years and 207.9% over 5 years, the stock has cooled recently, slipping 3.5% over the last week and 6.4% over the last month, and leaving year to date returns slightly negative at 0.6% and about 3.7% lower than a year ago. Those moves come against a backdrop...

Wondering if Healthpeak Properties is starting to look like a bargain after a tough run, or if the market sees trouble that is not obvious yet? Let us walk through what the numbers are really saying about its value. The stock is trading around $16.36, with returns of about -0.8% over the last week, -5.7% over the last month, and a much steeper -18.8% year to date, which has clearly tested investors' patience. Recently, the stock has been in focus as investors reassess listed healthcare REITs...

The recent 14% drop in Future FinTech Group Inc.'s ( NASDAQ:FTFT ) stock could come as a blow to insiders who purchased...